Controlled Release Formulations Of Levodopa And Uses Thereof

Patent No. EP2234963 (titled "Controlled Release Formulations Of Levodopa And Uses Thereof") was filed by Impax Laboratories on Dec 26, 2008. The application was issued on Apr 8, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LUIGIJan 7, 2021TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSJan 7, 2021D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2234963

IMPAX LABORATORIES
Application Number
EP08866933A
Filing Date
Dec 26, 2008
Status
Revoked
Jan 24, 2025
Publication Date
Apr 8, 2020